SEC Form 4 · accession 0001288123-17-000006
AGENUS INC · AGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean-Marie Cuillerot
Officer — Chief Medical Officer
Period of report
Jan 26, 2017
Accepted (ET)
Jan 30, 2017 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001098972
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option, Right to BuyF1 | $3.72 | Jan 26, 2017 | A | 100,000 | A | Jan 26, 2018 | Jan 26, 2027 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan and vests in three equal annual installments beginning on the one-year anniversary of the grant date.